Filing Details

Accession Number:
0000899243-19-018907
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-07-02 17:10:57
Reporting Period:
2019-07-02
Accepted Time:
2019-07-02 17:10:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1771917 Karuna Therapeutics Inc. KRTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245624 James Healy Sofinnova Investments, Inc.
3000 Sand Hill Road, 4-250
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-07-02 1,029,352 $0.00 1,029,352 No 4 C Indirect By Sofinnova Venture Partners X, L.P.
Common Stock Acquisiton 2019-07-02 700,000 $16.00 1,729,352 No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Sofinnova Venture Partners X, L.P.
No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2019-07-02 792,602 $0.00 1,029,352 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date.
  2. All shares held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X"), the general partner of SVP X, may be deemed to have sole voting power, and Dr. Michael F. Powell, Dr. James I. Healy, and Dr. Anand Mehra, the managing members of SM X, may be deemed to have shared power to vote these shares. Such individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.